Covestor’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-26
| Closed | – | – | 2867 |
|
|
2024
Q4 | $0 | Buy |
26
+2
| +8% | – | ﹤0.01% | 2865 |
|
|
2024
Q3 | $0 | Sell |
24
-2
| -8% | – | ﹤0.01% | 2891 |
|
|
2024
Q2 | $0 | Buy |
26
+16
| +160% | – | ﹤0.01% | 2870 |
|
|
2024
Q1 | $0 | Sell |
10
-1
| -9% | – | ﹤0.01% | 2872 |
|
|
2023
Q4 | $0 | Buy |
11
+5
| +83% | – | ﹤0.01% | 2861 |
|
|
2023
Q3 | $0 | Sell |
6
-1
| -14% | – | ﹤0.01% | 2856 |
|
|
2023
Q2 | $0 | Sell |
7
-1
| -13% | – | ﹤0.01% | 2787 |
|
|
2023
Q1 | $0 | Hold |
8
| – | – | ﹤0.01% | 2722 |
|
|
2022
Q4 | $0 | Sell |
8
-3
| -27% | – | ﹤0.01% | 2742 |
|
|
2022
Q3 | $0 | Sell |
11
-2
| -15% | – | ﹤0.01% | 2736 |
|
|
2022
Q2 | $0 | Sell |
13
-12
| -48% | – | ﹤0.01% | 2456 |
|
|
2022
Q1 | $0 | Sell |
25
-6
| -19% | – | ﹤0.01% | 2546 |
|
|
2021
Q4 | $1K | Buy |
+31
| New | +$1K | ﹤0.01% | 2022 |
|